Pascal and Francis Bibliographic Databases

Help

Search results

Your search

jo.\*:("Journal of immunotherapy (1997)")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 966

  • Page / 39
Export

Selection :

  • and

Adoptive Immunotherapy With CMV-specific Cytotoxic T Lymphocytes for Stem Cell Transplant Patients With Refractory CMV InfectionsLEI BAO; COWAN, Morton J; DUNHAM, Kimberly et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 3, pp 293-298, issn 1524-9557, 6 p.Article

Cancer and Innate Immune System Interactions: Translational Potentials for Cancer ImmunotherapyYANAN LIU; GANG ZENG.Journal of immunotherapy (1997). 2012, Vol 35, Num 4, pp 299-308, issn 1524-9557, 10 p.Article

Clinical Trial of the Intratumoral Administration of Labeled DC Combined With Systemic Chemotherapy for Esophageal CancerFUJIWARA, Shinichi; WADA, Hisashi; SAKAKIBARA, Mitsuru et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 6, pp 513-521, issn 1524-9557, 9 p.Article

Efficiency and Mechanism of Antigen-specific CD8+ T-cell Activation Using Synthetic Long PeptidesZANDVLIET, Maarten L; KESTER, Michel G. D; LIEMPT, Ellis Van et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 2, pp 142-153, issn 1524-9557, 12 p.Article

Immunologic Effects of an Orally Available BRAFV600E Inhibitor in BRAF Wild-type Murine ModelsVOSGANIAN, Gregory S; BOS, Rinke; SHERMAN, Linda A et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 6, pp 473-477, issn 1524-9557, 5 p.Article

Immunologic Evaluation of Peptides Derived From BCR/ABL-Out-of-Frame Fusion Protein in HLA A2.1 Transgenic MiceCASNICI, Claudia; VOLPE, Gisella; CROTTA, Katia et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 4, pp 321-328, issn 1524-9557, 8 p.Article

Improvement of Antitumor Effect of Intratumoral Injection of Immature Dendritic Cells Into Irradiated Tumor by Cyclophosphamide in Mouse Colon Cancer ModelSON, Cheol-Hun; DONG YEOK SHIN; KIM, Sung-Dae et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 8, pp 607-614, issn 1524-9557, 8 p.Article

Increase of Circulating B7-H4-Expressing CD68+ Macrophage Correlated With Clinical Stage of Lung CarcinomasCHENG CHEN; ZHU, Yi-Bei; YU SHEN et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 4, pp 354-358, issn 1524-9557, 5 p.Article

Interieukin-6 Inhibits Regulatory T Cells and Improves the Proliferation and Cytotoxic Activity of Cytokine-induced Killer CellsGUOHE LIN; JIN WANG; SHENGPING LI et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 4, pp 337-343, issn 1524-9557, 7 p.Article

Ipilimumab in Treatment-naive and Previously Treated Patients with Metastatic Melanoma: Retrospective Analysis of Efficacy and Safety Data from a Phase II TrialTHOMPSON, John A; HAMID, Omid; MINOR, David et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 1, pp 73-77, issn 1524-9557, 5 p.Article

PD-1 Blockade Augments Th1 and Th17 and Suppresses Th2 Responses in Peripheral Blood From Patients With Prostate and Advanced Melanoma CancerDULOS, John; CARVEN, Gregory J; JACOBS, Joannes F. M et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 2, pp 169-178, issn 1524-9557, 10 p.Article

Safety and Immunogenicity of Vaccination With MART-1 (26-35, 27L), gp100 (209-217, 210M), and Tyrosinase (368-376, 370D) In Adjuvant With PF-3512676 and GM-CSF In Metastatic MelanomaTARHINI, Ahmad A; SIYANG LENG; MOSCHOS, Stergios J et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 4, pp 359-366, issn 1524-9557, 8 p.Article

Targeted Tumor Therapy With a Fusion Protein of an Antiangiogenic Human Recombinant scFv and Yeast Cytosine DeaminaseSCHELLMANN, Nicole; PANJIDEH, Hossein; FASOLD, Patricia et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 7, pp 570-578, issn 1524-9557, 9 p.Article

Targeting Spatiotemporal Expression of CD137 on Tumor-infiltrating Cytotoxic T Lymphocytes as a Novel Strategy for Agonistic Antibody TherapyNOJI, Shuichi; HOSOI, Akihiro; TAKEDA, Kazuyoshi et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 6, pp 460-472, issn 1524-9557, 13 p.Article

Tumor-specific CD4+ Melanoma Tumor-infiltrating LymphocytesFRIEDMAN, Kevin M; PRIETO, Peter A; DEVILLIER, Laura E et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 5, pp 400-408, issn 1524-9557, 9 p.Article

A Functional Recombinant Human 4-1 BB Ligand for Immune Costimulatory Therapy of CancerMESECK, Marcia; TIANGUI HUANG; GE MA et al.Journal of immunotherapy (1997). 2011, Vol 34, Num 2, pp 175-182, issn 1524-9557, 8 p.Article

Adoptive Immunotherapy for Advanced Non-small Cell Lung Cancer Using Zoledronate-expanded γδ T Cells: A Phase I Clinical StudySAKAMOTO, Miki; NAKAJIMA, Jun; MURAKAWA, Tomohiro et al.Journal of immunotherapy (1997). 2011, Vol 34, Num 2, pp 202-211, issn 1524-9557, 10 p.Article

Enhanced T-cell-independent Antitumor Effect of Cyclophosphamide Combined With Anti-CD40 mAb and CpG in MiceJOHNSON, Erik E; BUHTOIAROV, Ilia N; BALDESHWILER, Mark J et al.Journal of immunotherapy (1997). 2011, Vol 34, Num 1, pp 76-84, issn 1524-9557, 9 p.Article

Identification of an HLA-DPB1*0501 Restricted Melan-A/MART-1 Epitope Recognized by CD4+ T Lymphocytes: Prevalence for Immunotherapy in Asian PopulationsZHAOTING MENG; YADONG WANG; SHUNCHANG JIAO et al.Journal of immunotherapy (1997). 2011, Vol 34, Num 7, pp 525-534, issn 1524-9557, 10 p.Article

Modulation of the Poliovirus Receptor Expression in Malignant Lymphocytes by Epigenetic AlterationsWEI WANG; LI GAO; XINRONG WANG et al.Journal of immunotherapy (1997). 2011, Vol 34, Num 4, pp 353-361, issn 1524-9557, 9 p.Article

Systemic Immune Tuning in Renal Cell Carcinoma: Favorable Prognostic Impact of TGF-β1 mRNA Expression in Peripheral Blood Mononuclear CellsBUSSE, Antonia; ASEMISSEN, Anne Marie; KEILHOLZ, Ulrich et al.Journal of immunotherapy (1997). 2011, Vol 34, Num 1, pp 113-119, issn 1524-9557, 7 p.Article

A Randomized Controlled Multicenter Study Comparing Recombinant Interleukin 2 (rIL-2) in Conjunction With Recombinant Interferon Alpha (IFN-α) Versus no Immunotherapy for Patients With Malignant Lymphoma Postautologous Stem Cell TransplantationNAGLER, Arnon; BERGER, Raanan; ACKERSTEIN, Aliza et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 3, pp 326-333, issn 1524-9557, 8 p.Article

A Recombinant Immunotoxin Targeting CD22 With Low Immunogenicity, Low Nonspecific Toxicity, and High Antitumor Activity in MiceHANSEN, Johanna K; WELDON, John E; LAIMAN XIANG et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 3, pp 297-304, issn 1524-9557, 8 p.Article

Accelerated Production of Antigen-specific T Cells for Preclinical and Clinical Applications Using Gas-permeable Rapid Expansion Cultureware (G-Rex)VERA, Juan F; BRENNER, Lara J; ROONEY, Cliona M et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 3, pp 305-315, issn 1524-9557, 11 p.Article

Anti-Melanoma Activity of the 9.2.27PE Immunotoxin in Dacarbazine Resistant CellsRISBERG, Karianne; FODSTAD, Øystein; ANDERSSON, Yvonne et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 3, pp 272-278, issn 1524-9557, 7 p.Article

  • Page / 39